• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

An Avian Influenza H5N1 Virus That Binds to a Human-Type Receptor

Anne

Senior Moderator
[SIZE=-1]
if itsn't at the rigt place, please moove it


http://jvi.asm.org/cgi/content/abstract/81/18/9950


Journal of Virology, September 2007, p. 9950-9955, Vol. 81, No. 18
0022-538X/07/$08.00+0 doi:10.1128/JVI.00468-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.[/SIZE]
An Avian Influenza H5N1 Virus That Binds to a Human-Type Receptor<sup>
dtri.gif
</sup>


Prasert Auewarakul,<sup>1</sup><sup>*</sup> Ornpreya Suptawiwat,<sup>1</sup> Alita Kongchanagul,<sup>1</sup> Chak Sangma,<sup>6</sup> Yasuo Suzuki,<sup>7</sup> Kumnuan Ungchusak,<sup>4</sup> Suda Louisirirotchanakul,<sup>1</sup> Hatairat Lerdsamran,<sup>1</sup> Phisanu Pooruk,<sup>1</sup> Arunee Thitithanyanont,<sup>2</sup> Chakrarat Pittayawonganon,<sup>4</sup> Chao-Tan Guo,<sup>7</sup> Hiroaki Hiramatsu,<sup>7</sup> Wipawee Jampangern,<sup>3</sup> Supamit Chunsutthiwat,<sup>5</sup> and Pilaipan Puthavathana<sup>1</sup> Faculty of Medicine, Siriraj Hospital,<sup>1</sup> Faculty of Science,<sup>2</sup> Faculty of Tropical Medicine,<sup>3</sup> Mahidol University, Bangkok, Thailand; Bureau of Epidemiology,<sup>4</sup> Department of Disease Control, Bangkok, Thailand,<sup>5</sup> Faculty of Science, Kasetsart University, Bangkok, Thailand,<sup>6</sup> College of Life and Health Sciences, Chubu University, Kasugai, Japan<sup>7</sup>
Received 5 March 2007/ Accepted 18 June 2007


<!-- ABS --> Avian influenza viruses preferentially recognize sialosugar<sup> </sup>chains terminating in sialic acid-
agr.gif
2,3-galactose (SA
agr.gif
2,3Gal),<sup> </sup>whereas human influenza viruses preferentially recognize SA
agr.gif
2,6Gal.<sup> </sup>A conversion to SA
agr.gif
2,6Gal specificity is believed to be one of<sup> </sup>the changes required for the introduction of new hemagglutinin<sup> </sup>(HA) subtypes to the human population, which can lead to pandemics.<sup> </sup>Avian influenza H5N1 virus is a major threat for the emergence<sup> </sup>of a pandemic virus. As of 12 June 2007, the virus has been<sup> </sup>reported in 45 countries, and 312 human cases with 190 deaths<sup> </sup>have been confirmed. We describe here substitutions at position<sup> </sup>129 and 134 identified in a virus isolated from a fatal human<sup> </sup>case that could change the receptor-binding preference of HA<sup> </sup>of H5N1 virus from SA
agr.gif
2,3Gal to both SA
agr.gif
2,3Gal and SA
agr.gif
2,6Gal.
Molecular<sup> </sup>modeling demonstrated that the mutation may stabilize SA
agr.gif
2,6Gal<sup> </sup>in its optimal cis conformation in the binding pocket. The mutation<sup> </sup>was found in approximately half of the viral sequences directly<sup> </sup>amplified from a respiratory specimen of the patient. Our data<sup> </sup>confirm the presence of H5N1 virus with the ability to bind<sup> </sup>to a human-type receptor in this patient and suggest the selection<sup> </sup>and expansion of the mutant with human-type receptor specificity<sup> </sup>in the human host environment.
 
Back
Top